Diabetic Ulcer Treatment Market Share

  • Report ID: 4585
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Diabetic Ulcers Treatment Market Regional Analysis:

North American Market Insights

North America region is likely to hold over 38.8% market share by 2035, attributed to the increasing spending on healthcare and the presence of key market players in the region. The Centers for Medicare & Medicaid Services has reported that US healthcare spending in 2020 totaled USD 4.1 trillion, which represents 19.7% of the nation’s gross domestic product. Additionally, the increasing adoption of wound care products, coupled with the surging awareness regarding chronic wound care, the rise in technologically advanced research and development activities, and the huge diabetic population in the North America region are expected to fuel the diabetic ulcers treatment market growth in the region during the forecast period. The increasing urbanization and change in lifestyle, which include improper eating habits and a lack of exercise, are estimated to project market growth in the region as these factors increase the risk of diabetes. The rising number of the age-old population who have diabetes and foot ulcer issues are further predicted to boost the market’s growth in the region.

Diabetic-Ulcer-Treatment-Market-Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of diabetic ulcers treatment is assessed at USD 9.29 billion.

The global diabetic ulcers treatment market size was valued at over USD 8.81 billion in 2025 and is expected to expand at a CAGR of over 6.1%, surpassing USD 15.93 billion revenue by 2035.

North America diabetic ulcers treatment market is predicted to capture 38.8% share by 2035, driven by the increasing spending on healthcare and the presence of key market players in the region.

Key players in the market include Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Medtronic Plc, Hill-Rom Holdings, Inc., ConvaTec Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos